Through the support of two previous awards, Manus has made significant progress in applying its proprietary platform to develop a fermentation-based approach for artemisinin production. This third award will expand and extend this work to enable low-cost manufacturing of this life-saving drug.

‍

“Malaria remains one of the most significant health problems worldwide. With the continued support of the Bill & Melinda Gates Foundation, we are breaking new ground in the application of advanced fermentation technology to the challenge of producing artemisinin and making this important medicine more readily available to those who need it,” said Dr. Christine Santos, Chief Technology Officer of Manus.

‍

About Manus

Manus leverages rapid advances in Biology to produce complex natural ingredients used in our daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals, and agricultural chemicals. Using its advanced fermentation technology, Manus recreates natural processes for next-generation industrial biomanufacturing and provides sustainable and cost-effective sources of ingredients for health, wellness, and nutrition. To learn more, visit www.manusbio.com, or contact info@manusbio.com.

‍